Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
Radiology|May 1, 1994
Accurate frameless registration of MR and CT images of the head: applications in planning surgery and radiation therapyD L Hill, D J Hawkes, M J Gleeson, et al.
Brain : a Journal of Neurology|April 29, 1998
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complicationsM Samuel, E Caputo, D J Brooks, et al.
Journal of Computer Assisted Tomography|July 1, 1990
Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studiesS S Gill, D G Thomas, N Van Bruggen, et al.
Health Systems (Basingstoke, England)|November 8, 2021
Establishing an SEIR-based framework for local modelling of COVID-19 infections, hospitalisations and deathsR M Wood, A C Pratt, B J Murch, et al.
Oncogene|September 28, 2005
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinomaC T Miller, L Lin, A M Casper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosomeF Favero, N McGranahan, M Salm, et al.
Brain : a Journal of Neurology|August 1, 1997
Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET studyM Samuel, A O Ceballos-Baumann, N Turjanski, et al.
Neurology|February 1, 1997
Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcomeL M Li, F Cendes, C Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2018
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerB Basu, M G Krebs, R Sundar, et al.
Oncogene|February 18, 2014
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer modelG Kim, M Ouzounova, A A Quraishi, et al.
Pageof 38